MELD 3.0
Model for End-Stage Liver Disease
Formula
MELD 3.0 = 4.56 × ln(Bilirubin) + 0.82 × (137 − Na) − 0.24 × (137 − Na) × ln(Creatinine) + 9.09 × ln(INR) + 11.14 × ln(Creatinine) + 1.85 × (Female sex = 1, else 0) + 1.83 × (Albumin < 3.5) − 7Kim et al., Hepatology 2021. Score range 6–40. Creatinine capped at 3.0 mg/dL. Na constrained to 125–137 mEq/L.
mg/dL (max 3.0)
mg/dL (min 1.0)
min 1.0
mEq/L (constrained 125–137)
g/dL
—
Advertisement · 728×90
Child-Pugh Score
Cirrhosis severity classification
Scoring (1–3 points each parameter)
Bilirubin: <2 = 1pt, 2–3 = 2pts, >3 = 3pts |
Albumin: >3.5 = 1pt, 2.8–3.5 = 2pts, <2.8 = 3pts |
INR: <1.7 = 1pt, 1.7–2.2 = 2pts, >2.2 = 3pts |
Ascites: None = 1pt, Mild = 2pts, Moderate/Severe = 3pts |
Encephalopathy: None = 1pt, Grade I–II = 2pts, Grade III–IV = 3ptsClass A: 5–6 pts (1yr survival ~100%) · Class B: 7–9 pts (~80%) · Class C: 10–15 pts (~45%)
—
Advertisement · 728×90
VOCAL-Penn
Cirrhosis Surgical Risk Score
Formula (Mahmud et al., Gastroenterology 2021)
VOCAL-Penn Score = 0.03 × Age + 0.92 × ln(Bilirubin) + 0.70 × ln(Creatinine) + 1.17 × ln(INR) + 0.14 × ASA class − 0.30 × Albumin + 0.56 × Ascites(1=yes) + 0.97 × Emergency(1=yes)30-day mortality risk derived from logistic regression. Higher score = higher surgical risk.
mg/dL
mg/dL
g/dL
—
Advertisement · 728×90
Hepatitis B Serology Interpreter
HBV infection status based on serologic markers
Serologic Markers
HBsAg — Hepatitis B surface antigen: present in active infection |
Anti-HBs — Surface antibody: indicates immunity (vaccine or resolved) |
HBeAg — e antigen: marker of high replication |
Anti-HBe — e antibody: suggests lower replication |
Anti-HBc IgM — Core IgM: acute infection marker |
Anti-HBc Total — Core total: past or present infection
Select result for each marker
Hepatitis B surface antigen
Surface antibody
Hepatitis B e antigen
e antibody
Core antibody IgM
Core antibody total (IgG + IgM)